CAS
QTTB icon

Coppell Advisory Solutions’s Q32 Bio QTTB Stock Holding History

Coppell Advisory Solutions’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$7 Hold
1
– – ﹤0.01% 1716
2023
Q3 		$30 Hold
1
– – ﹤0.01% 1183
2023
Q2 		$10 Buy
+1
New +$18 ﹤0.01% 1430
2023
Q1 		– Sell
-1
Closed -$30 – 1125
2022
Q4 		$30 Buy
+1
New +$27 ﹤0.01% 1185

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

Coppell Advisory Solutions's QTTB Position: Q4 2023 in Review

Coppell Advisory Solutions held its Q32 Bio (QTTB) position steady in Q4 2023 at 1 share worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Coppell Advisory Solutions first reported a position in QTTB in Q4 2022 and has held it in 4 quarters since. The position peaked at $30 in Q3 2023. 57 funds tracked by Wall St. Rank hold QTTB as of Q4 2023.

  • Coppell Advisory Solutions held 1 share of Q32 Bio worth $7 as of Q4 2023.
  • Coppell Advisory Solutions left its Q32 Bio share count unchanged in Q4 2023.
  • Q32 Bio made up ﹤0.01% of Coppell Advisory Solutions's portfolio in Q4 2023, its #1716 holding.
  • Coppell Advisory Solutions first reported a position in Q32 Bio in Q4 2022 and has held it in 4 quarters since.
  • Coppell Advisory Solutions's Q32 Bio position peaked at $30 in Q3 2023.
  • 57 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2023.

Based on Coppell Advisory Solutions's 13F filing for Q4 2023, filed 14 Feb 2024.